Two Sigma Investments’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-36,500
Closed -$922K 3910
2021
Q4
$922K Buy
36,500
+8,900
+32% +$246K ﹤0.01% 2630
2021
Q3
$742K Buy
27,600
+15,800
+134% +$455K ﹤0.01% 2900
2021
Q2
$376K Sell
11,800
-13,000
-52% -$413K ﹤0.01% 3327
2021
Q1
$872K Sell
24,800
-14,500
-37% -$504K ﹤0.01% 2446
2020
Q4
$1.26M Buy
39,300
+6,000
+18% +$185K ﹤0.01% 1819
2020
Q3
$1.05M Buy
33,300
+5,500
+20% +$182K ﹤0.01% 1719
2020
Q2
$991K Buy
27,800
+10,700
+63% +$372K ﹤0.01% 1542
2020
Q1
$492K Sell
17,100
-25,500
-60% -$668K ﹤0.01% 1942
2019
Q4
$1M Buy
42,600
+8,100
+23% +$181K ﹤0.01% 2185
2019
Q3
$622K Buy
34,500
+22,600
+190% +$373K ﹤0.01% 2371
2019
Q2
$186K Buy
+11,900
New +$234K ﹤0.01% 3109
2018
Q4
Sell
-23,500
Closed -$776K 3390
2018
Q3
$776K Buy
23,500
+16,200
+222% +$605K ﹤0.01% 2159
2018
Q2
$322K Sell
7,300
-12,900
-64% -$499K ﹤0.01% 2906
2018
Q1
$843K Sell
20,200
-8,300
-29% -$383K ﹤0.01% 2122
2017
Q4
$1.3M Buy
+28,500
New +$1.12M ﹤0.01% 1773

Other funds holding PETS

Two Sigma Investments's PETS Position: Q4 2024 in Review

Two Sigma Investments sold out of PetMed Express (PETS) in Q4 2024, closing a stake of 20,389 shares — an estimated $75K sold.

Two Sigma Investments first reported a position in PETS in Q3 2013 and held it in 26 quarters. The position peaked at $7.17M in Q3 2018. 86 funds tracked by Wall St. Rank hold PETS as of Q4 2024.

  • Two Sigma Investments reported no remaining PetMed Express position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Investments sold 20,389 PetMed Express shares in Q4 2024, an estimated $75K.
  • Two Sigma Investments first reported a position in PetMed Express in Q3 2013 and held it in 26 quarters.
  • Two Sigma Investments's PetMed Express position peaked at $7.17M in Q3 2018.
  • 86 funds tracked by Wall St. Rank held PetMed Express as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.